Financial Performance - The company reported a total revenue of 616 million yuan for Q1 2025, representing a year-on-year increase of 7.78% [1] - The net profit attributable to shareholders reached 182 million yuan, up 8.13% year-on-year [1] - The gross margin improved to 86.31%, an increase of 1.68% compared to the previous year, while the net margin rose to 56.12%, up 0.71% [1] Key Financial Metrics - The company's operating expenses, including sales, management, and financial costs, totaled 109 million yuan, accounting for 17.7% of revenue, which is a 0.93% increase year-on-year [1] - Earnings per share (EPS) increased to 0.78 yuan, reflecting an 8.33% year-on-year growth [1] - The cash flow from operating activities per share decreased significantly by 76.42% to 0.23 yuan [1] Business Model and Market Position - The company has a strong return on invested capital (ROIC) of 21.97% and a net profit margin of 47.13%, indicating high value addition in its products or services [3] - The company has a healthy cash asset position and has cumulatively raised 140 million yuan in financing while distributing 1.346 billion yuan in dividends since its listing [3] - The collaboration with China Resources is aimed at promoting vitamin D supplements, enhancing market penetration and resource sharing [5] Fund Holdings - The largest fund holding in the company is by Tianzhi New Consumption Mixed Fund, which holds 13,200 shares, marking a new entry into the top ten holdings [4] - The fund's current scale is 0.17 billion yuan, with a recent net value of 0.8065, reflecting a decline of 0.74% from the previous trading day [4]

Core Insights - The company reported a revenue of 218.71 billion yuan for 2024, a decrease of 3.46% year-on-year [2] - The net profit attributable to shareholders was 46.19 billion yuan, down 14.88% year-on-year [2] - The company achieved a significant improvement in operating cash flow, with a net cash flow from operating activities of 15.77 billion yuan, an increase of 43% [2] Financial Performance - Revenue breakdown: - Construction revenue: 132.18 billion yuan, down 4.5% - Infrastructure revenue: 55.09 billion yuan, down 1.0% - Real estate revenue: 3.06 billion yuan, down 0.8% - Survey and design revenue: 10.8 billion yuan, down 7.9% [2] - Gross profit: 97.85 billion yuan, down 2.6% year-on-year [2] - Gross margin: 9.86%, up 0.03 percentage points year-on-year [2] - Net margin: 2.87%, down 0.38 percentage points year-on-year [2] - Total expenses ratio: 4.95%, up 0.24 percentage points year-on-year [2] Accounts Receivable and Liabilities - Accounts receivable stood at 317.09 billion yuan, an increase of 23.05% year-on-year [3] - Asset-liability ratio was 75.81%, up 0.99 percentage points year-on-year [3] - Total impairment losses amounted to 20.09 billion yuan, an increase of 5.79 billion yuan year-on-year [3] Contractual Performance - New contracts signed in 2024 totaled 4.5 trillion yuan, an increase of 4.1% year-on-year [3] - Breakdown of new contracts: - Construction: 4.08 trillion yuan, up 5.4% - Infrastructure: 1.41 trillion yuan, up 21.1% - Overseas contracts: 221.3 billion yuan, up 19.0% [3] - New contracts signed in January-February 2025 reached 713.6 billion yuan, up 5.6% year-on-year [3] Future Projections - Expected net profit attributable to shareholders for 2025-2027: - 2025: 48.27 billion yuan, up 4.51% - 2026: 50.98 billion yuan, up 5.61% - 2027: 54.67 billion yuan, up 7.25% [4] - Corresponding P/E ratios are projected to be 4.61, 4.36, and 4.07 [4]